Senti Biosciences, Inc. - Common Stock, $0.0001 par value (SNTI)

CUSIP: 81726A100

Q4 2022 13F Holders as of 31 Dec 2022

Security type / class
Equity / Common Stock, $0.0001 par value
Total 13F shares
12,403,151
Total 13F value
$16,580,774
Holder snapshot 6 signals
Share change
-1,064,706
SEC-reported price per share
$1.41
Number of holders
26
Value change
-$1,583,124
Number of buys
11
Number of sells
12
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
31,203,430

Security key

81726A100

Report period

Q4 2022

Institutions

26

Top holders

10

SNTI full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2025 Senti Biosciences Holdings, Inc. SEC filings Senti Biosciences Holdings, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of SNTI - Senti Biosciences, Inc. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
PRICE T ROWE ASSOCIATES I...
Disclosed value leader
PRICE T ROWE ASSOCIATES I...
Comparable rows
0/15
Latest evidence
30 Sep 2022
13F 3/4/5 Highest disclosed value: $8,714,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

PRICE T ROWE ASSOCIATES INC /MD/ has the largest disclosed position value at $8.71M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens PRICE T ROWE ASSOCIATES INC /MD/'s linked filing trail.
Disclosed position value Top 5
PRICE T ROWE ASSOCIATES INC /MD/ $8.71M
NEA Management Company, LLC $8.23M
ARK Investment Management LLC $4.53M
Artal Group S.A. $2.29M
Curt A. Herberts III $1.98M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
13F
—
denominator unverified
$8,714,000
4,015,483 shares
 — 30 Sep 2022
NEA Management Company, LLC
13F
Company
13F
—
denominator unverified
$8,233,000
4,429,725 shares
 — 30 Sep 2022
ARK Investment Management LLC
13F
Company
13F
—
denominator unverified
$4,530,000
2,087,696 shares
 — 30 Sep 2022
Artal Group S.A.
13F
Company
13F
—
denominator unverified
$2,291,000
1,055,555 shares
 — 30 Sep 2022
Curt A. Herberts III
3/4/5
Chief Operating Officer
3/4/5
—
denominator unverified
$1,984,889
454,208 shares
 — 08 Jun 2022
INTEL CORP
13F
Company
13F
—
denominator unverified
$1,293,000
595,665 shares
 — 30 Sep 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
26
Shares
12,403,151
Rows available
26
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2022 vs Q3 2025 Across Filers

Q3 2025 holders
1
Q4 2022 holders
26
Holder diff
25
Investor Q3 2025 Shares Q4 2022 Shares Share Diff Share Chg % Q3 2025 value Q4 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .